These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36369336)

  • 21. Global, regional, and national mortality of tuberculosis attributable to alcohol and tobacco from 1990 to 2019: A modelling study based on the Global Burden of Disease study 2019.
    Jinyi W; Zhang Y; Wang K; Peng P
    J Glob Health; 2024 Jan; 14():04023. PubMed ID: 38175959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990-2019.
    Mousavi SE; Nejadghaderi SA; Khabbazi A; Alizadeh M; Sullman MJM; Kaufman JS; Collins GS; Safiri S
    Sci Rep; 2022 Nov; 12(1):19297. PubMed ID: 36369238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the burden of anorexia nervosa in the Middle East and North Africa region between 1990 and 2019.
    Safiri S; Noori M; Nejadghaderi SA; Mousavi SE; Karamzad N; Sullman MJM; Pirotta S; Collins GS; Abdollahi M; Kolahi AA
    J Eat Disord; 2022 Dec; 10(1):192. PubMed ID: 36496474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol Collaborators
    Lancet; 2018 Sep; 392(10152):1015-1035. PubMed ID: 30146330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of Alzheimer's disease and other types of dementia in the Middle East and North Africa region, 1990-2019.
    Safiri S; Noori M; Nejadghaderi SA; Mousavi SE; Sullman MJM; Araj-Khodaei M; Collins GS; Kolahi AA; Gharagozli K
    Age Ageing; 2023 Mar; 52(3):. PubMed ID: 36995136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019.
    Safiri S; Noori M; Nejadghaderi SA; Shamekh A; Karamzad N; Sullman MJM; Grieger JA; Collins GS; Abdollahi M; Kolahi AA
    Int J Eat Disord; 2023 Feb; 56(2):394-406. PubMed ID: 36301044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney cancer in the Middle East and North Africa region: a 30-year analysis (1990-2019).
    Safiri S; Hassanzadeh K; Ghaffari Jolfayi A; Mousavi SE; Motlagh Asghari K; Nejadghaderi SA; Naghdi-Sedeh N; Noori M; Sullman MJM; Collins GS; Kolahi AA
    Sci Rep; 2024 Jun; 14(1):13710. PubMed ID: 38877130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035.
    Chen Y; Ma L; Han Z; Xiong P
    Diabetes Obes Metab; 2024 Sep; 26(9):3998-4010. PubMed ID: 38957939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017.
    Gouda HN; Charlson F; Sorsdahl K; Ahmadzada S; Ferrari AJ; Erskine H; Leung J; Santamauro D; Lund C; Aminde LN; Mayosi BM; Kengne AP; Harris M; Achoki T; Wiysonge CS; Stein DJ; Whiteford H
    Lancet Glob Health; 2019 Oct; 7(10):e1375-e1387. PubMed ID: 31537368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
    Sang S; Chu C; Zhang T; Chen H; Yang X
    Ecotoxicol Environ Saf; 2022 Jun; 238():113588. PubMed ID: 35525115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of tension-type headache in the Middle East and North Africa region, 1990-2019.
    Safiri S; Kolahi AA; Noori M; Nejadghaderi SA; Aslani A; Sullman MJM; Farhoudi M; Araj-Khodaei M; Collins GS; Kaufman JS; Gharagozli K
    J Headache Pain; 2022 Jul; 23(1):77. PubMed ID: 35794530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
    Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
    J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
    ; Murray CJ; Barber RM; Foreman KJ; Abbasoglu Ozgoren A; Abd-Allah F; Abera SF; Aboyans V; Abraham JP; Abubakar I; Abu-Raddad LJ; Abu-Rmeileh NM; Achoki T; Ackerman IN; Ademi Z; Adou AK; Adsuar JC; Afshin A; Agardh EE; Alam SS; Alasfoor D; Albittar MI; Alegretti MA; Alemu ZA; Alfonso-Cristancho R; Alhabib S; Ali R; Alla F; Allebeck P; Almazroa MA; Alsharif U; Alvarez E; Alvis-Guzman N; Amare AT; Ameh EA; Amini H; Ammar W; Anderson HR; Anderson BO; Antonio CA; Anwari P; Arnlöv J; Arsic Arsenijevic VS; Artaman A; Asghar RJ; Assadi R; Atkins LS; Avila MA; Awuah B; Bachman VF; Badawi A; Bahit MC; Balakrishnan K; Banerjee A; Barker-Collo SL; Barquera S; Barregard L; Barrero LH; Basu A; Basu S; Basulaiman MO; Beardsley J; Bedi N; Beghi E; Bekele T; Bell ML; Benjet C; Bennett DA; Bensenor IM; Benzian H; Bernabé E; Bertozzi-Villa A; Beyene TJ; Bhala N; Bhalla A; Bhutta ZA; Bienhoff K; Bikbov B; Biryukov S; Blore JD; Blosser CD; Blyth FM; Bohensky MA; Bolliger IW; Bora Başara B; Bornstein NM; Bose D; Boufous S; Bourne RR; Boyers LN; Brainin M; Brayne CE; Brazinova A; Breitborde NJ; Brenner H; Briggs AD; Brooks PM; Brown JC; Brugha TS; Buchbinder R; Buckle GC; Budke CM; Bulchis A; Bulloch AG; Campos-Nonato IR; Carabin H; Carapetis JR; Cárdenas R; Carpenter DO; Caso V; Castañeda-Orjuela CA; Castro RE; Catalá-López F; Cavalleri F; Çavlin A; Chadha VK; Chang JC; Charlson FJ; Chen H; Chen W; Chiang PP; Chimed-Ochir O; Chowdhury R; Christensen H; Christophi CA; Cirillo M; Coates MM; Coffeng LE; Coggeshall MS; Colistro V; Colquhoun SM; Cooke GS; Cooper C; Cooper LT; Coppola LM; Cortinovis M; Criqui MH; Crump JA; Cuevas-Nasu L; Danawi H; Dandona L; Dandona R; Dansereau E; Dargan PI; Davey G; Davis A; Davitoiu DV; Dayama A; De Leo D; Degenhardt L; Del Pozo-Cruz B; Dellavalle RP; Deribe K; Derrett S; Des Jarlais DC; Dessalegn M; Dharmaratne SD; Dherani MK; Diaz-Torné C; Dicker D; Ding EL; Dokova K; Dorsey ER; Driscoll TR; Duan L; Duber HC; Ebel BE; Edmond KM; Elshrek YM; Endres M; Ermakov SP; Erskine HE; Eshrati B; Esteghamati A; Estep K; Faraon EJ; Farzadfar F; Fay DF; Feigin VL; Felson DT; Fereshtehnejad SM; Fernandes JG; Ferrari AJ; Fitzmaurice C; Flaxman AD; Fleming TD; Foigt N; Forouzanfar MH; Fowkes FG; Paleo UF; Franklin RC; Fürst T; Gabbe B; Gaffikin L; Gankpé FG; Geleijnse JM; Gessner BD; Gething P; Gibney KB; Giroud M; Giussani G; Gomez Dantes H; Gona P; González-Medina D; Gosselin RA; Gotay CC; Goto A; Gouda HN; Graetz N; Gugnani HC; Gupta R; Gupta R; Gutiérrez RA; Haagsma J; Hafezi-Nejad N; Hagan H; Halasa YA; Hamadeh RR; Hamavid H; Hammami M; Hancock J; Hankey GJ; Hansen GM; Hao Y; Harb HL; Haro JM; Havmoeller R; Hay SI; Hay RJ; Heredia-Pi IB; Heuton KR; Heydarpour P; Higashi H; Hijar M; Hoek HW; Hoffman HJ; Hosgood HD; Hossain M; Hotez PJ; Hoy DG; Hsairi M; Hu G; Huang C; Huang JJ; Husseini A; Huynh C; Iannarone ML; Iburg KM; Innos K; Inoue M; Islami F; Jacobsen KH; Jarvis DL; Jassal SK; Jee SH; Jeemon P; Jensen PN; Jha V; Jiang G; Jiang Y; Jonas JB; Juel K; Kan H; Karch A; Karema CK; Karimkhani C; Karthikeyan G; Kassebaum NJ; Kaul A; Kawakami N; Kazanjan K; Kemp AH; Kengne AP; Keren A; Khader YS; Khalifa SE; Khan EA; Khan G; Khang YH; Kieling C; Kim D; Kim S; Kim Y; Kinfu Y; Kinge JM; Kivipelto M; Knibbs LD; Knudsen AK; Kokubo Y; Kosen S; Krishnaswami S; Kuate Defo B; Kucuk Bicer B; Kuipers EJ; Kulkarni C; Kulkarni VS; Kumar GA; Kyu HH; Lai T; Lalloo R; Lallukka T; Lam H; Lan Q; Lansingh VC; Larsson A; Lawrynowicz AE; Leasher JL; Leigh J; Leung R; Levitz CE; Li B; Li Y; Li Y; Lim SS; Lind M; Lipshultz SE; Liu S; Liu Y; Lloyd BK; Lofgren KT; Logroscino G; Looker KJ; Lortet-Tieulent J; Lotufo PA; Lozano R; Lucas RM; Lunevicius R; Lyons RA; Ma S; Macintyre MF; Mackay MT; Majdan M; Malekzadeh R; Marcenes W; Margolis DJ; Margono C; Marzan MB; Masci JR; Mashal MT; Matzopoulos R; Mayosi BM; Mazorodze TT; Mcgill NW; Mcgrath JJ; Mckee M; Mclain A; Meaney PA; Medina C; Mehndiratta MM; Mekonnen W; Melaku YA; Meltzer M; Memish ZA; Mensah GA; Meretoja A; Mhimbira FA; Micha R; Miller TR; Mills EJ; Mitchell PB; Mock CN; Mohamed Ibrahim N; Mohammad KA; Mokdad AH; Mola GL; Monasta L; Montañez Hernandez JC; Montico M; Montine TJ; Mooney MD; Moore AR; Moradi-Lakeh M; Moran AE; Mori R; Moschandreas J; Moturi WN; Moyer ML; Mozaffarian D; Msemburi WT; Mueller UO; Mukaigawara M; Mullany EC; Murdoch ME; Murray J; Murthy KS; Naghavi M; Naheed A; Naidoo KS; Naldi L; Nand D; Nangia V; Narayan KM; Nejjari C; Neupane SP; Newton CR; Ng M; Ngalesoni FN; Nguyen G; Nisar MI; Nolte S; Norheim OF; Norman RE; Norrving B; Nyakarahuka L; Oh IH; Ohkubo T; Ohno SL; Olusanya BO; Opio JN; Ortblad K; Ortiz A; Pain AW; Pandian JD; Panelo CI; Papachristou C; Park EK; Park JH; Patten SB; Patton GC; Paul VK; Pavlin BI; Pearce N; Pereira DM; Perez-Padilla R; Perez-Ruiz F; Perico N; Pervaiz A; Pesudovs K; Peterson CB; Petzold M; Phillips MR; Phillips BK; Phillips DE; Piel FB; Plass D; Poenaru D; Polinder S; Pope D; Popova S; Poulton RG; Pourmalek F; Prabhakaran D; Prasad NM; Pullan RL; Qato DM; Quistberg DA; Rafay A; Rahimi K; Rahman SU; Raju M; Rana SM; Razavi H; Reddy KS; Refaat A; Remuzzi G; Resnikoff S; Ribeiro AL; Richardson L; Richardus JH; Roberts DA; Rojas-Rueda D; Ronfani L; Roth GA; Rothenbacher D; Rothstein DH; Rowley JT; Roy N; Ruhago GM; Saeedi MY; Saha S; Sahraian MA; Sampson UK; Sanabria JR; Sandar L; Santos IS; Satpathy M; Sawhney M; Scarborough P; Schneider IJ; Schöttker B; Schumacher AE; Schwebel DC; Scott JG; Seedat S; Sepanlou SG; Serina PT; Servan-Mori EE; Shackelford KA; Shaheen A; Shahraz S; Shamah Levy T; Shangguan S; She J; Sheikhbahaei S; Shi P; Shibuya K; Shinohara Y; Shiri R; Shishani K; Shiue I; Shrime MG; Sigfusdottir ID; Silberberg DH; Simard EP; Sindi S; Singh A; Singh JA; Singh L; Skirbekk V; Slepak EL; Sliwa K; Soneji S; Søreide K; Soshnikov S; Sposato LA; Sreeramareddy CT; Stanaway JD; Stathopoulou V; Stein DJ; Stein MB; Steiner C; Steiner TJ; Stevens A; Stewart A; Stovner LJ; Stroumpoulis K; Sunguya BF; Swaminathan S; Swaroop M; Sykes BL; Tabb KM; Takahashi K; Tandon N; Tanne D; Tanner M; Tavakkoli M; Taylor HR; Te Ao BJ; Tediosi F; Temesgen AM; Templin T; Ten Have M; Tenkorang EY; Terkawi AS; Thomson B; Thorne-Lyman AL; Thrift AG; Thurston GD; Tillmann T; Tonelli M; Topouzis F; Toyoshima H; Traebert J; Tran BX; Trillini M; Truelsen T; Tsilimbaris M; Tuzcu EM; Uchendu US; Ukwaja KN; Undurraga EA; Uzun SB; Van Brakel WH; Van De Vijver S; van Gool CH; Van Os J; Vasankari TJ; Venketasubramanian N; Violante FS; Vlassov VV; Vollset SE; Wagner GR; Wagner J; Waller SG; Wan X; Wang H; Wang J; Wang L; Warouw TS; Weichenthal S; Weiderpass E; Weintraub RG; Wenzhi W; Werdecker A; Westerman R; Whiteford HA; Wilkinson JD; Williams TN; Wolfe CD; Wolock TM; Woolf AD; Wulf S; Wurtz B; Xu G; Yan LL; Yano Y; Ye P; Yentür GK; Yip P; Yonemoto N; Yoon SJ; Younis MZ; Yu C; Zaki ME; Zhao Y; Zheng Y; Zonies D; Zou X; Salomon JA; Lopez AD; Vos T
    Lancet; 2015 Nov; 386(10009):2145-91. PubMed ID: 26321261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological Features of Neurological Disorders in North Africa and the Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
    Moradinazar M; Shakiba M; Ramazani Y; Kanjouri S; Shokohyzade R; Darvishi S; Shakiba E
    Arch Iran Med; 2023 Feb; 26(2):76-85. PubMed ID: 37543927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.